The acquisition announcement comes alongside Agilent’s public offering of senior notes amounting to about $850 million, set to mature in 10 years. (Wikimedia Commons) () Diving deeper into the cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results